Prevalence and Barriers to Management of Hypertension in Asia: Challenges and Opportunities in the Asian Century

Heart Lung and Circulation

Volumn 25, Issue 3, 2016, Pages 207-208

  Wang, Lexin ^a  

^a CHARLES STURT UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

AGE; ANXIETY; ASIA; ATTITUDE TO HEALTH; AUSTRALIA; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CHINA; COST EFFECTIVENESS ANALYSIS; DEPRESSION; EDITORIAL; HEALTH CARE ACCESS; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HEALTH EDUCATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INDIA; LIFESTYLE MODIFICATION; MALAYSIA; MORBIDITY; MORTALITY; NUTRITIONAL DEFICIENCY; OBESITY; PREVALENCE; PRIORITY JOURNAL; RURAL AREA; SELF CONCEPT; SMOKING; STRESS; THAILAND; UNITED KINGDOM; UNITED STATES; URBAN AREA; WELLBEING;

ASIA; HUMANS; HYPERTENSION; PREVALENCE;

EID: 84958678812     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2015.12.093     Document Type: Editorial

References (21)

1. Australia in the Asian Century White Paper. (accessed on 7/12/2015). http://www.murdoch.edu.au/ALTC-Fellowship/_document/Resources/australia-in-the-asian-century-white-paper.pdf.
2. Patel V, Chatterji S, Chisholm D, Ebrahim S, Gopalakrishna G, Mathers C, et al. Chronic diseases and injuries in India. (accessed 7/12/2015). http://www.who.int/choice/publications/Chronic_diseaseIndia.pdf.
3. Denniss R. The Journal in 2012 and beyond. Heart Lung Cir 2012, 21:129-130.
4. Huang S.L., Chen Q., Yan J., He X.J. Medical Research in China: Where Does It Go Am J Med Qual 2013, 28:172-173.
5. Yang G., Wang Y., Zeng Y., Gao G.F., Liang X., Zhou M., et al. Rapid health transition in China, 1990-2010: Findings from the global burden of disease study 2010. Lancet. 2013, 381:1987-2015.
6. Anchala R1, Kannuri N.K., Pant H., Khan H., Franco O.H., Di Angelantonio E., et al. Hypertension in India: a systematic review and meta-analysis of prevalence, awareness, and control of hypertension. J Hypertens 2014, 32:1170-1177.
7. Yao DK, Su W, Zheng X, Wang LX. Knowledge and understanding of hypertension among Tibetan people in Lhasa, Tibet. Heart Lung Circ 12/2015; . doi:10.1016/j.hlc.2015.11.007.
8. Zheng X., Yao D.K., Ma C.R.Z., Tang J., Wang T.R., Zhang H.H., et al. Prevalence, self-awareness, treatment and control of hypertension in Lhasa, Tibet. Clin Exper Hypertens 2012, 34:328-333.
9. Wang J., Ning X., Yang L., Lu H., Tu J., Jin W., et al. Trends of hypertension prevalence, awareness, treatment and control in rural areas of northern China during 1991-2011. J Hum Hypertens 2014, 28:25-31.
10. Wang J., Zhang L2, Wang F., Liu L., Wang H. Prevalence, awareness, treatment, and control of hypertension in China: results from a national survey. Am J Hypertens 2014, 27:1355-1361. China National Survey of Chronic Kidney Disease Working Group.
11. Aekplakorn W., Sangthong R., Kessomboon P., Putwatana P., Inthawong R., Taneepanichskul S., et al. Changes in prevalence, awareness, treatment and control of hypertension in Thai population, 2004-2009: Thai National Health Examination Survey III-IV. J Hypertens 2012, 30:1734-1742. National Health Examination Survey IV study group.
12. Rampal L1, Rampal S., Azhar M.Z., Rahman A.R. Prevalence, awareness, treatment and control of hypertension in Malaysia: a national study of 16,440 subjects. Public Health 2008, 122:11-18.
13. Egan B.M., Zhao Y., Axon R.N. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA 2010, 303:2043-2050.
14. Michel Joffres M., Falaschetti E., Gillespie C., Robitaille C., Loustalot F., Poulter N., et al. Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional study. BMJ Open 2013, 3:e003423.
15. Australian Health Survey: Health Service Usage and Health Related Actions, 2011-12. (accessed on 8/12/2015). http://www.abs.gov.au/ausstats/abs@.nsf/Lookup/322DB1B539ACCC6CCA257B39000F316C?opendocument.
16. Janus E.D., Bunker S.J., Kilkkinen A., Mc Namara K., Philpot B., Tideman P., et al. Prevalence, detection and drug treatment of hypertension in a rural Australian population: the Greater Green Triangle risk factor study 2004-2006. Intern Med J 2008, 38:879-886.
17. Wang L.X., Wei T.M. Blood pressure control in patients with primary hypertension: a community-based study. Clin Exper Hypertens 2006, 82:41-46.
18. Khatib R., Schwalm J.D., Yusuf S., Haynes R.B., McKee M., Khan M., et al. Patient and healthcare provider barriers to hypertension awareness, treatment and follow up: a systematic review and meta-analysis of qualitative and quantitative studies. PLoS One 2014, 9:e84238.
19. Wang L.X. Physician-related barriers to hypertension management. Medi Princ Pract 2004, 13:282-285.
20. Bovet P., Gervasoni J.P., Mkamba M., Balampama M., Lengeler C., et al. Low utilization of health care services following screening for hypertension in dar es salaam [Tanzania]: A prospective population-based study. BMC Public Health. 2008, 8:407.
21. Wang L.X., Li J.T. Role of educational intervention in the management of comorbid depression and hypertension. Blood Press 2003, 12:198-202.